North America Synthetic Biology Market Business Strategy, Development Status, Emerging Technologies, Future Plans and Trends by Forecast 2028

According to a new market research study on “North America Synthetic Biology Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Products, Technology, and Application” is expected to reach US$ 15,223.61 million by 2028 from US$ 4,313.62 million in 2021. The market is estimated to grow at a CAGR of 19.7% from 2021 to 2028. The report provides trends prevailing in the North America synthetic biology market along with the drivers and restraints pertaining to the market growth. Growing investments in synthetic biology is the major factor driving the growth of the North America synthetic biology market. However, renewed regulations for biotechnology may hamper the growth of the market hinders the growth of North America synthetic biology market.   

Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00025392

The List of Companies - 

  1. Agilent Technologies, Inc.
  2. Amyris
  3. Codexis
  4. Genscript Biotech corporation
  5. Integrated DNA Technologies
  6. Merck KGaA
  7. New England Biolabs
  8. Novozymes A/S
  9. Thermo Fisher Scientific
  10. Twist Bioscience

 Synthetic Biology: Driving Innovation and Investment in North America

Synthetic biology, a rapidly evolving field, is transforming industries like chemicals, agriculture, pharmaceuticals, and energy. A surge in startups offering gene synthesis products and services is contributing to this growth.

Key Market Drivers:

  • Startup Innovation:
    • Companies like Benchling (CAD tools), GenScript (gene synthesis), Ginkgo Bioworks (organism engineering), Transcriptis (bioinformatics/cloud labs), and Glowee (consumer products) are driving innovation.
  • Increased Investment:
    • Despite the COVID-19 pandemic, the bioeconomy experienced accelerated growth in 2020.
    • 56 synthetic biology businesses raised over US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion in the same period of 2019.
  • Biopharma Advancements:
    • New biopharma businesses are utilizing synthetic biology to enhance cell treatment, gene therapy, and early cancer detection.
  • Technological Advancements:
    • The introduction of new features and technologies is attracting new customers and expanding market reach.

North America Synthetic Biology Market Outlook:

  • The increasing demand for synthetic biology-based techniques, fueled by rising investments, is driving market growth across North America.
  • The North America synthetic biology market is projected to experience a notable CAGR during the forecast period.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights    

Comments

Popular posts from this blog

Permanent Magnet Market Size, Share, Segmentation, Analysis by Recent Trends, Development and Growth by 2031

Graphite Market Opportunities, Challenges, Strategies and Forecasts by 2031

Europe Voice Biometrics Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2028